biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by GoBio14on Jan 17, 2014 4:24pm

141 Views

Post# 22105941

Touche

Noobski:

Very well put. My apologies if that was the result of anything I printed. BTI does sound like it has amazing potential, not to mention the "moral" benefits to society and to those unfortunate enough to be suffering from disease where potenial cures are currently ineffective due to the BBB.
Thank you for both your post and perspective. GOOD LUCK! (apologies about the capitals :-)

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports